RGC Regencell Bioscience Holdings Limited - Ordinary Shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Oct 31, 2025
$6.82
· of 52w range
· above low
· to high
$4.5152w low
$69.0052w high
Market Cap
$3.37B
P/E
-9.5
EPS
$-0.72
your badges
52W Range
$5–$69
Analyst Rating
·
Price Target
·
P/E
-9.5
ROE
-54.8%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
RGC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$6.82
Market Cap
$3.37B
P/E
-9.5
EPS
$-0.72
ROE
-54.8%
52W Range
$5–$69
RGC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| June 16, 2025 | 38-for-1 | Forward |
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-0.722020-06-30 → 2025-06-30
Free Cash Flow$-3M2022-06-30 → 2025-06-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | RGC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -9.55Y avg ≈-6.5 | ≈-6.5 | · | · | |
| P/B | 693.95Y avg ≈433.8 | ≈433.8 | · | · | |
| Price / FCF | -1032.55Y avg ≈-645.9 | ≈-645.9 | · | · | |
| Price / Cash Flow | -1083.15Y avg ≈-677.6 | ≈-677.6 | · | · | |
| Price / Tangible Book | 693.95Y avg ≈433.8 | ≈433.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | RGC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -50.5%5Y avg ≈-105.5% | ≈-105.5% | · | · | |
| ROE | -54.8%5Y avg ≈-42.7% | ≈-42.7% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | RGC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 7.45Y avg ≈19.4 | ≈19.4 | · | · | |
| Quick Ratio | 7.45Y avg ≈19.2 | ≈19.2 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| R&D Expense | $948.3K | $1M | $2M | $3M | $438.3K | $386.2K | |
| SG&A Expense | $3M | $4M | $4M | $5M | $941.5K | $311.9K | |
| Operating Expenses | $4M | $5M | $6M | $8M | $1M | $812.4K | |
| Operating Income | $-4M | $-5M | $-6M | $-8M | $-1M | $-812.4K | |
| Interest Income | $185.8K | $248.0K | $85.4K | $10.7K | · | · | |
| Pretax Income | $-4M | $-4M | $-6M | $-8M | $-1M | $-812.4K | |
| Net Income | $-4M | $-4M | $-6M | $-7M | $-1M | $-812.4K | |
| EPS (Basic) | $-0.72 | $-0.87 | $-1.19 | $-0.58 | $0.13 | $0.08 | |
| EPS (Diluted) | $-0.72 | $-0.87 | $-1.19 | $-0.58 | $-0.13 | $-0.08 | |
| Shares (Basic) | 494,488,908 | 494,488,908 | 494,488,908 | 12,805,707 | 10,000,000 | 10,000,000 | |
| Shares (Diluted) | 494,488,908 | 494,488,908 | 494,488,908 | 12,805,707 | 10,000,000 | 10,000,000 | |
| EBITDA | $-4M | $-5M | $-6M | $-8M | $-1M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2M | $3M | $2M | $6M | $59.4K | $387.0K | |
| Short-term Investments | $2M | $5M | $10M | $10M | · | · | |
| Prepaid Expense | $5.8K | $152.8K | $56.5K | $27.6K | $7.4K | · | |
| Current Assets | $5M | $8M | $12M | $16M | $66.8K | $387.0K | |
| PP&E (Net) | $215.4K | $141.7K | $440.8K | $712.6K | $81.9K | $108.3K | |
| PP&E (Gross) | $1M | $925.9K | $917.0K | $898.7K | $117.8K | · | |
| Accum. Depreciation | $857.3K | $784.2K | $476.2K | $186.1K | $36.0K | $9.5K | |
| Total Assets | $6M | $8M | $13M | $18M | $340.1K | $514.0K | |
| Accrued Liabilities | $348.4K | $125.3K | $158.1K | $151.1K | $573.0K | $95.0K | |
| Current Liabilities | $663.7K | $193.6K | $606.9K | $577.8K | $4M | $3M | |
| Capital Leases | $231.6K | $25.9K | $25.4K | $360.3K | · | · | |
| Total Liabilities | $895.3K | $219.5K | $632.3K | $938.0K | $4M | $3M | |
| Common Stock | $4.9K | $130 | $130 | $130 | $100 | $100 | |
| Paid-in Capital | · | · | · | $29M | $256 | $256 | |
| Retained Earnings | $-25M | $-22M | $-17M | $-11M | $-4M | $-3M | |
| AOCI | $-64.8K | $-45.8K | $-86.7K | · | · | · | |
| Stockholders' Equity | $5M | $8M | $12M | $17M | $-4M | $-3M | |
| Liabilities + Equity | $6M | $8M | $13M | $18M | $340.1K | $514.0K | |
| Shares Outstanding | 494,488,908 | 494,488,908 | 494,488,908 | 494,488,908 | 10,000,000 | 10,000,000 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $244.8K | $449.3K | $922.6K | $3M | · | · | |
| Amort. of Intangibles | · | · | · | $454.2K | · | · | |
| Operating Cash Flow | $-3M | $-4M | $-5M | $-5M | $-767.3K | $-726.6K | |
| CapEx | $152.7K | $5.4K | $27.4K | $780.9K | · | $117.8K | |
| Investing Cash Flow | $3M | $5M | $59.0K | $-11M | · | $-117.8K | |
| Financing Cash Flow | · | $102.3K | $134.9K | $22M | $439.7K | $988.1K | |
| Net Change in Cash | $-542.1K | $1M | $-5M | $6M | $-327.6K | $143.7K | |
| Free Cash Flow | $-3M | $-4M | $-5M | $-6M | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| ROA | -50.5% | -40.8% | -38.3% | -82.7% | -315.3% | · | |
| ROE | -54.8% | -42.5% | -40.4% | -116.2% | 40.5% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | 41.9 | 19.1 | 28.5 | 0.0 | · | |
| Quick Ratio | 7.4 | 41.1 | 19.1 | 28.4 | 0.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.01 | $0.63 | $0.92 | $1.31 | $-0.40 | · | |
| Cash Flow / Share | $-0.01 | $-0.31 | $-0.38 | $-0.41 | · | · | |
| Cash / Share | $0.00 | $0.23 | $0.12 | $0.49 | $0.01 | · | |
| EPS (TTM) | $-0.72 | $-0.87 | $-1.19 | $-0.58 | $-0.13 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Net Income TTM | $-4M | $-4M | $-6M | $-7M | $-1M | · | |
| Market Cap | $8.43B | $1M | $8M | $12M | · | · | |
| P/E | -23.7 | -0.1 | -0.5 | -1.6 | · | · | |
| P/B | 1733.7 | 0.1 | 0.7 | 0.7 | · | · | |
| P / Tangible Book | 1733.7 | 0.1 | 0.7 | 0.7 | · | · | |
| P / Cash Flow | -2706.2 | -0.3 | -1.6 | -2.2 | · | · | |
| P / FCF | -2579.7 | -0.3 | -1.6 | -2.0 | · | · | |
| Earnings Yield | -4.2% | -984.2% | -196.3% | -63.7% | · | · |
No quarterly filings for RGC
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Net Income | $-4M | $-4M | $-6M | $-7M | $-1M |
| Diluted EPS | $-0.72 | $-0.87 | $-1.19 | $-0.58 | $-0.13 |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Current Ratio | 7.4 | 41.9 | 19.1 | 28.5 | 0.0 |
| Quick Ratio | 7.4 | 41.1 | 19.1 | 28.4 | 0.0 |
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|---|
| Free Cash Flow | $-3M | $-4M | $-5M | $-6M | · |
Institutional owners (13F) 40 filers · $10.0M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
40
Value held
$10.0M
New positions
17
Exited positions
12
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 17 (-3 vs prior Q) | 12 (+8 vs prior Q) | 14 (+6 vs prior Q) | 6 (0 vs prior Q) | +825K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $2,570,046 | 422,011 | 25.75% | Shares |
| Alyeska Investment Group, L.P. | $2,535,029 | 416,261 | 25.40% | Shares |
| Legal & General Group Plc | $778,974 | 128,000 | 7.80% | Shares |
| JANE STREET GROUP, LLC | $598,940 | 98,348 | 6.00% | Shares |
| CITADEL ADVISORS LLC | $458,577 | 75,300 | 4.59% | Put option |
| JANE STREET GROUP, LLC | $396,459 | 65,100 | 3.97% | Put option |
| XTX Topco Ltd | $365,771 | 60,061 | 3.66% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $290,493 | 47,700 | 2.91% | Put option |
| Amundi | $287,198 | 47,159 | 2.88% | Shares |
| UBS Group AG | $263,137 | 43,208 | 2.64% | Shares |
| Quadrature Capital Ltd | $254,258 | 41,750 | 2.55% | Shares |
| CITADEL ADVISORS LLC | $202,188 | 33,200 | 2.03% | Call option |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $140,856 | 23,129 | 1.41% | Shares |
| Squarepoint Ops LLC | $134,199 | 22,036 | 1.34% | Shares |
| FOX RUN MANAGEMENT, L.L.C. | $126,008 | 20,691 | 1.26% | Shares |
| CIBC Asset Management Inc | $93,128 | 15,292 | 0.93% | Shares |
| BANK OF AMERICA CORP /DE/ | $91,313 | 14,994 | 0.91% | Shares |
| TWO SIGMA INVESTMENTS, LP | $87,733 | 14,406 | 0.88% | Shares |
| JANE STREET GROUP, LLC | $78,561 | 12,900 | 0.79% | Call option |
| Vident Advisory, LLC | $68,202 | 11,199 | 0.68% | Shares |
| MORGAN STANLEY | $30,768 | 5,052 | 0.31% | Shares |
| BlackRock, Inc. | $29,994 | 4,925 | 0.30% | Shares |
| State of Wyoming | $24,786 | 4,070 | 0.25% | Shares |
| Federation des caisses Desjardins du Quebec | $17,070 | 2,803 | 0.17% | Shares |
| Aquatic Capital Management LLC | $12,533 | 2,058 | 0.13% | Shares |
| CITIGROUP INC | $11,151 | 1,831 | 0.11% | Shares |
| SIMPLEX TRADING, LLC | $10,456 | 1,717 | 0.10% | Shares |
| GROUP ONE TRADING LLC | $5,804 | 953 | 0.06% | Shares |
| Russell Investments Group, Ltd. | $4,628 | 760 | 0.05% | Shares |
| OSAIC HOLDINGS, INC. | $3,909 | 642 | 0.04% | Shares |
| Rockefeller Capital Management L.P. | $3,075 | 505 | 0.03% | Shares |
| EverSource Wealth Advisors, LLC | $3,033 | 498 | 0.03% | Shares |
| Blue Trust, Inc. | $1,315 | 216 | 0.01% | Shares |
| Larson Financial Group LLC | $1,023 | 168 | 0.01% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $642 | 99 | 0.01% | Shares |
| Bare Financial Services, Inc | $183 | 30 | 0.00% | Shares |
| Bell Investment Advisors, Inc | $122 | 20 | 0.00% | Shares |
| Ameritas Advisory Services, LLC | $116 | 19 | 0.00% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $18 | 3 | 0.00% | Shares |
| Silver Grove Financial Group, Inc. | $6 | 1 | 0.00% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Regencell (BVI) Limited, Yat-Gai Au ×8 filings | July 11, 2025 | 88.60% | Amendment | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 2 insiders · 0 officers · 2 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Evana Yee Wah Hui | Director | May 27, 2026 D | · | 0 | 0 | $0 |
| William Wing Yan Lo DR | Director | May 27, 2026 D | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Oct 31, 2025